S Chand and Company Ltd
NSE:SCHAND
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S Chand and Company Ltd
NSE:SCHAND
|
IN |
|
N
|
Navamedic ASA
OSE:NAVA
|
NO |
|
MFS Inc
TSE:196A
|
JP |
|
Bath & Body Works Inc
NYSE:BBWI
|
US |
|
D
|
Doxa AB
STO:DOXA
|
SE |
Wall St Price Targets
SCHAND Price Targets Summary
S Chand and Company Ltd
According to Wall Street analysts, the average 1-year price target for
SCHAND is 296.82 INR with a low forecast of 293.91 INR and a high forecast of 305.55 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SCHAND's stock price target?
Price Target
296.82
INR
According to Wall Street analysts, the average 1-year price target for
SCHAND is 296.82 INR with a low forecast of 293.91 INR and a high forecast of 305.55 INR.
What is the Revenue forecast for S Chand and Company Ltd?
Projected CAGR
10%
Over the last 12 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 3 years is 10%.
What is the Operating Income forecast for S Chand and Company Ltd?
Projected CAGR
13%
Over the last 12 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 2 years is 13%.
What is the Net Income forecast for S Chand and Company Ltd?
Projected CAGR
19%
Over the last 12 years, the compound annual growth rate for Net Income has been 6%. The projected CAGR for the next 3 years is 19%.